Cytokinetics (NASDAQ:CYTK) Earns Buy Rating from HC Wainwright
Cytokinetics (NASDAQ:CYTK – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC ...
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...
Cytokinetics started at buy by Stifel, aficamten highlighted
Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...
Fintel on MSN21h
Stifel Initiates Coverage of Cytokinetics (CYTK) with Buy Recommendation
Fintel reports that on January 22, 2025, Stifel initiated coverage of Cytokinetics (NasdaqGS:CYTK) with a Buy recommendation.
Buy Rating for Esperion Based on Strong Clinical Data and Market Adoption of NEXLETOL and NEXLIZET
JMP Securities analyst Jason Butler reiterated a Buy rating on Esperion (ESPR – Research Report) today and set a price target of $7.00.Invest ...
Edgewise rated as a new Hold at Stifel on a balanced risk-reward setup
Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...
Buy Rating for Rigel: Promising Clinical Developments and Strong Commercial Performance
Analyst Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Rigel (RIGL – Research Report) and keeping the price target at ...
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Canaccord Genuity analyst Caitlin Burrows initiated coverage on Orthofix Medical Inc. OFIX with a Buy rating and announced a ...
Allbirds (NASDAQ:BIRD) Price Target Lowered to $8.00 at Morgan Stanley
Allbirds (NASDAQ:BIRD – Get Free Report) had its target price lowered by investment analysts at Morgan Stanley from $12.00 to $8.00 in a research note issued to investors on Tuesday,Benzinga reports.